Northpointe Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Northpointe Capital's LLY Position: Q3 2019 in Review
Northpointe Capital reduced its Eli Lilly (LLY) stake by 54% in Q3 2019, selling an estimated $1.45M and leaving 10,955 shares worth $1.23M. The position accounts for 0.47% of the portfolio, ranked #76.
Northpointe Capital first reported a position in LLY in Q2 2013 and has held it in 7 quarters since. The position peaked at $4.11M in Q1 2015. 1,525 funds tracked by Wall St. Rank hold LLY as of Q3 2019.
- Northpointe Capital held 10,955 shares of Eli Lilly worth $1.23M as of Q3 2019.
- Northpointe Capital sold 13,043 Eli Lilly shares in Q3 2019, an estimated $1.45M.
- Eli Lilly made up 0.47% of Northpointe Capital's portfolio in Q3 2019, its #76 holding.
- Northpointe Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 7 quarters since.
- Northpointe Capital's Eli Lilly position peaked at $4.11M in Q1 2015.
- 1,525 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.
Based on Northpointe Capital's 13F filing for Q3 2019, filed 16 Oct 2019.